Ascendis Pharma A/S
SEC CIK 1612042 · ASND · last insider filing 2026-06-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bienaime Jean Jacques | Director | filed 2026 - 2026 |
| Mikkelsen JAN Moller | Director | filed 2026 - 2026 |
| Cha Albert | Director | filed 2026 - 2026 |
| Morrison Lisa | Director | filed 2026 - 2026 |
| Fairey William | Director | filed 2026 - 2026 |
| Imani Siham | Director | filed 2026 - 2026 |
| Holtug Lars | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Smith Scott Thomas | EVP & Chief Financial Officer | filed 2026 - 2026 |
| Jensen Flemming Steen | See Remarks | filed 2026 - 2026 |
| Jensen Michael Wolff | EVP, Chief Legal Officer | filed 2026 - 2026 |
| Sprogoe Kennett | See Remarks | filed 2026 - 2026 |
| Pedersen Anni Lotte Kirstine Sonderbjerg | EVP & Chief Admin Officer | filed 2026 - 2026 |
| Bodenhoff Mads | SVP & PAO | filed 2026 - 2026 |
| Shu Aimee | EVP & Chief Medical Officer | filed 2026 - 2026 |
| Wu Jay Donovan | EVP & President US Market | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.